Literature DB >> 2316235

Aminoglycoside volume of distribution in pediatric patients.

Y M Shevchuk1, D M Taylor.   

Abstract

Pharmacokinetic parameters of three aminoglycoside antibiotics were studied retrospectively in 218 pediatric patients to determine an apparent volume of distribution (Vd) for this age group and to determine if Vd is significantly different in pediatric patients compared with adults. Data on patients considered for inclusion in the study were obtained from the files of the aminoglycoside monitoring services at Saskatoon University Hospital and Regina General Hospital. Both services use a computer program that calculates pharmacokinetic parameters using the Sawchuk-Zaske method. Children between the ages of 1 and 16 years with normal renal function from whom serum concentration had been obtained were included in the study. Exclusion criteria included abnormal or unstable renal function, cystic fibrosis, and pregnancy. The mean age of the pediatric group was 8.65 +/- 5.37 years. Average values for Vd and half-life were 0.34 L/kg and 2.3 h, respectively. No strong correlation was found between the Vd (L/kg) and age. The patients were subdivided into three age groups: 1-4.9 years, 5-9.9 years, and 10-16 years. Group 1 (1-4.9 years) had a larger Vd than the other groups and the Vd of all three groups were significantly different from the estimated Vd of 0.20 L/kg for adult patients. A "normal" pediatric value for the Vd of aminoglycosides could not be determined; however, the Vd in children is significantly larger than the Vd in adults and dosage regimens should be adjusted accordingly.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316235     DOI: 10.1177/106002809002400313

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  3 in total

1.  Gentamicin dosing for pediatric patients with congenital heart disease.

Authors:  Brady S Moffett; Sara J D Bork; Antonio R Mott
Journal:  Pediatr Cardiol       Date:  2010-06-12       Impact factor: 1.655

Review 2.  Pharmacokinetics of anti-infective agents in paediatric patients.

Authors:  D R Butler; R J Kuhn; M H Chandler
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

3.  Special population considerations and regulatory affairs for clinical research.

Authors:  Kristin N Grimsrud; Catherine M T Sherwin; Jonathan E Constance; Casey Tak; Athena F Zuppa; Michael G Spigarelli; Nicole L Mihalopoulos
Journal:  Clin Res Regul Aff       Date:  2015
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.